Could Contentious IPR Trade Terms Bloat Healthcare Costs, Sink Pharma’s Image?
Executive Summary
Intellectual property rights terms in various trade agreements could have serious ramifications not just on healthcare costs but also on the legitimate trade of generic drugs between developing nations, say some experts. Pharma’s image may be at stake too.